Searchable abstracts of presentations at key conferences in endocrinology

ea0038fp5 | (1) | SFEBES2015

Generation of GnRH neurons from human embryonic stem cells and induced pluripotent stem cells of healthy individuals and patients with Kallmann’s syndrome

Poliandri Ariel , Miller Duncan , Dunkel Leo

GnRH neurons are vital for reproductive competence. These neurons originate mainly in the nasal epithelium and migrate to the preoptic region of the hypothalamus during foetal development. Defective migration may result in Hypogonadotropic Hypogonadism (HH), a condition in which puberty is never or only partially achieved.Little is known about the molecular ontogeny and regulation of GnRH neurons. Their anatomical localisation and small numbers (about 10...

ea0037oc2.3 | Reproduction | ECE2015

Restoration of fertility in hypogonadal LH receptor null background male mice by a constitutive active mutant FSH receptor

Oduwole Olayiwola , Peltoketo Hellevi , Poliandri Ariel , Vengadabady Laura , Huhtaniemi Ilpo

The gonadotropic hormones, LH and FSH are critical regulators of normal sexual functions including steroidogenesis and gametogenesis. Their essential role is underscored by the development of various hypogonadal phenotypes arising from genetic mutations. Constitutive activation of their cognate receptors also disturbs their function. We earlier showed that transgenic expression of an activating mouse Fshr mutant (mFSHRD580H) in granulosa c...

ea0041gp117 | Endocrine Tumours | ECE2016

FSH supplementation increases the growth of PC-3 human prostate cancer cell xenograft in gonadotropin-suppressed nude mice

Oduwole Olayiwola , Poliandri Ariel , Rawson Phil , Rahman Nafis , Koechling Wolfgang , Huhtaniemi Ilpo

Gonadotropin-releasing hormone (GnRH) analogues are now the standard hormonal treatment for prostate cancer. A fundamental difference between GnRH agonist and antagonist treatment is the permanent suppression of both gonadotropins (LH and FSH) by antagonist, while a rebound in FSH is associated with agonist treatment. The benefits of antagonist include the immediate onset of action and profound long-term suppression of FSH, suggested to be an independent growth factor in prost...

ea0038oc6.3 | Advances in reproduction and signalling | SFEBES2015

Mutations in HS6ST1 are causal in self-limited delayed puberty as well as idiopathic hypogonadotropic hypogonadism

Howard Sasha , Poliandri Ariel , Storr Helen , Metherell Louise , Cabrera Claudia , Barnes Michael , Warren Helen , Wehkalampi Karoliina , Guasti Leo , Dunkel Leo

Background: Self-limited delayed puberty (DP) often segregates in an autosomal dominant pattern, suggesting that inheritance is conferred by a small number of genes. However, the underlying genetic background is mostly unknown. By comparison, many genes have been identified where loss-of-function mutations lead to hypogonadotropic hypogonadism (HH). Despite likely overlap between the pathophysiology of delayed puberty and conditions of GnRH deficiency, few studies have examine...

ea0020s28.1 | Receptor Modulators | ECE2009

Diverse actions of the nuclear receptor corepressor RIP140 in metabolic regulation

Parker Malcolm , Christian Mark , Kiskinis Evangelos , Fritah Asmaa , Poliandri Ariel , Steel Jenny , Hallberg Magnus , Herzog Birger , Seth Asha , Dilworth Steven , White Roger

PGC1 and RIP140 are key regulators of nuclear receptor signalling that control metabolic gene expression in adipose tissue, liver and muscle. PGC1 promotes whereas RIP140 represses the expression of a network of catabolic genes in adipose and muscle. Thus mice devoid of RIP140 accumulate less fat in adipose tissue and liver while mitochondrial biogenesis and respiration is increased in type 2 muscle fibres; as a consequence, the mice maintain their insulin sensitivity as they ...